These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 2139274

  • 1. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H, Rinck G, Bitterling T, Orfanos CE.
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [Abstract] [Full Text] [Related]

  • 2. Determination of acitretin and 13-cis-acitretin in skin.
    Laugier JP, Berbis P, Brindley C, Bun H, Geiger JM, Privat Y, Durand A.
    Skin Pharmacol; 1989 Jan; 2(4):181-6. PubMed ID: 2534733
    [Abstract] [Full Text] [Related]

  • 3. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice.
    Berne B, Rollman O, Vahlquist A.
    Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):146-52. PubMed ID: 2150173
    [Abstract] [Full Text] [Related]

  • 4. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
    Brouwer KR, McNamara PJ.
    Drug Metab Dispos; 1989 Aug; 17(6):652-5. PubMed ID: 2575502
    [Abstract] [Full Text] [Related]

  • 5. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR, Geiger JM.
    Acta Derm Venereol Suppl (Stockh); 1989 Aug; 146():206-7. PubMed ID: 2532847
    [Abstract] [Full Text] [Related]

  • 6. Residual plasma concentrations of acitretin (Ro 10-1670) and its metabolite (Ro 13-7652) after chronic administration.
    Berbis P, Bun H, Al Mallah NR, Durand A, Rognin C, Geiger JM, Privat Y.
    Dermatologica; 1988 Aug; 177(4):244-6. PubMed ID: 2976002
    [Abstract] [Full Text] [Related]

  • 7. [Retinoids: the new status. Maintenance therapy, disorders of resorption in "non-responders", interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin].
    Orfanos CE.
    Hautarzt; 1989 Mar; 40(3):123-9. PubMed ID: 2523875
    [Abstract] [Full Text] [Related]

  • 8. Cis-trans interconversion of acitretin in man.
    Geiger JM, Brindley CJ.
    Skin Pharmacol; 1988 Mar; 1(4):230-6. PubMed ID: 2978787
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions.
    Park HD, Kim HK, Kim JW, Kim DW, Lee JH, Huh W, Youn JI, Kim HG, Kim YG, Kim MH, Lee SY.
    Transfusion; 2008 Nov; 48(11):2395-400. PubMed ID: 18657077
    [Abstract] [Full Text] [Related]

  • 10. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H, Bauer R, Brindley C, Orfanos CE, Plewig G, Wokalek H, Hoting E.
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [Abstract] [Full Text] [Related]

  • 11. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H, Sönnichsen N.
    Acta Derm Venereol Suppl (Stockh); 1989 Sep; 146():176-7. PubMed ID: 2532846
    [No Abstract] [Full Text] [Related]

  • 12. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
    Ruzicka T, Sommerburg C, Braun-Falco O, Köster W, Lengen W, Lensing W, Letzel H, Meigel WN, Paul E, Przybilla B.
    Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
    [Abstract] [Full Text] [Related]

  • 13. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
    Brouwer KR, McNamara PJ.
    Drug Metab Dispos; 1989 Apr; 17(6):646-51. PubMed ID: 2575501
    [Abstract] [Full Text] [Related]

  • 14. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G, Nau H, Hendrickx AG, Peterson PE, Hummler H.
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [Abstract] [Full Text] [Related]

  • 15. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. II. Etretinate.
    Eisenhardt EU, Bickel MH.
    Drug Metab Dispos; 1994 Nov; 22(1):31-5. PubMed ID: 8149886
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K, Jansén CT, Geiger JM, Bjerke JR, Falk ES, Gip L, Hjorth N, Lauharanta J, Mork NJ, Reunala T.
    Acta Derm Venereol; 1989 Nov; 69(1):35-40. PubMed ID: 2563606
    [Abstract] [Full Text] [Related]

  • 17. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL, Blummel JJ, Kerkhof PC, Gerritsen RM.
    Eur J Dermatol; 2000 Nov; 10(7):517-21. PubMed ID: 11056421
    [Abstract] [Full Text] [Related]

  • 18. Teratogenicity of etretinate during early pregnancy in the rat and its correlation with maternal plasma concentrations of the drug.
    Agnish ND, Vane FM, Rusin G, DiNardo B, Dashman T.
    Teratology; 1990 Jul; 42(1):25-33. PubMed ID: 2144063
    [Abstract] [Full Text] [Related]

  • 19. Acitretin : A Review of its Pharmacology and Therapeutic Use.
    Pilkington T, Brogden RN.
    Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
    [Abstract] [Full Text] [Related]

  • 20. Use of retinoids in the treatment of psoriasis.
    Warren EW, Khanderia U.
    Clin Pharm; 1989 May; 8(5):344-51. PubMed ID: 2663325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.